Safety and efficacy of glecaprevir/pibrentasvir for the treatment of HCV genotype 1-6: Results of the HCV-TARGET study

Sterling, R; Zeuzem, S; Welzel, T; Manns, MP; Reddy, R; Terrault, N; Ben Ari, Z; Vodkin, I; Toor, A; Vainorius, M; Akushevich, L; Fried, MW; Nelson, DR; Sulkowski, M

JOURNAL OF HEPATOLOGY, 2019; 70 (1): E241